Funding for this research was provided by:
The LuMind IDSC Foundation
Received: 28 August 2020
Accepted: 21 December 2020
First Online: 11 January 2021
Ethics approval and consent to participate
: Ethical approval was granted by WIRB-Copernicus Group Company IRB. The approval number is 20192259. All caregivers provided informed consent.
: Not applicable.
: HH is President and CEO and JAH is CSO of the LuMind IDSC Foundation. This study was conducted by DGI Clinical Inc. in which KR is President, Chief Science Officer and a shareholder. KK, JS, TD, SS, SEH and TD are employees of DGI Clinical Inc. In the last 3 years, KR has also attended an advisory board meeting for Roche/Genentech and Nutricia and has given two talks sponsored by Nutricia.